Secondary outcomes are cTnT, NT-proBNP, inflammatory/endothelial biomarkers (hs-CRP, IL-6, MMP-9, VEGF, HMGB1), and angina-related parameters (attack frequency, symptom severity). The gene discussed is VEGFA; the disease is angina pectoris.